Endometrial carcinoma:
Primary drugs:
Progestins or tamoxifen (Nolvadex)
Other useful drugs/modalities:
Doxorubicin (Adriamycin)
Cisplatin (Platinol)
Carboplatin (Paraplatin)
Ovarian cancer:
Cyclophosphamide (Cytoxan)
Melphalan (Alkeran)
Flurouracil (5-FU)
Vincristine (Oncovin)
Altretamine (Hexalen)
Bleomycin (Blenoxane)
Cervical cancer:
Lomustine (CCNU,CeeNU)
Lyclophosphamide (Cytoxan)
Methotrexate
Mitomycin (Mutamycin)
Interferon
13-cis-Retinoic acid
Breast cancer:
Adjuvant chemotherapy or tamoxifen following surgery
Combination chemotherapy or hormonal medication for late recurrence
Paclitaxel (Taxol)
Mitoxantrone (Novantrone)
Prednisone (Deltasone)
Aminoglutethimide
Megestrol
Androgens
Choriocarcinoma (trophoblastic neoplasm)
Etoposide (VP-16,VePe-sid) plus cisplatin (Platinol)
Vinblastine (Velban)
Mercaptopurine (Purinethol)
Chlorambucil (Leukeran)
Polycythemia vera
Busulfan (Myleran)
Radioactive P32
Testicular cancer:
Combination chemotherapy:
Etoposide (VP-16,VePe-sid)
Dactinomycin (Cosmegen)
Plicamycin (Mithramycin)
Prostatic cancer:
Estrogens
GnRH agonist plus flutamide (Eulexin)
Estramustine (Emcyf)
Progestins
Wilms' tumor:
Vincristine (Oncovin) plus dactinomycin (Cosmegen) (after surgery and radiation treatment)
Neuroblastoma:
Cyclophosphamide (Cytoxan) plus doxorubicin (Adriamycin) plus vincristine (Oncovin)
Daunorubicin (DaunoXome)
Thyroid cancer:
Radioiodine (I131)
Adrenal carcinoma:
Primary drug:
Mitotane (Lysodren)
Stomach or pancreatic carcinoma:
FLurouracil (5-FU) plus doxorubicin (Adriamycin), mitomycin (Mutamycin)
Hydroxyurea (Hydrea)
Colon cancer:
Flurouracil (5-FU) plus leucovorin or interferon (or both)
Nitrosoureas
Carcinoid:
Doxorubicin (Adriamycin) + cyclophosphamide (Cytoxan)
Fluorouracil (5-FU)
Octreotide
Streptozocin (Zanosar)
Methysergide (Sansert) (supportive therapy)
Insulinoma:
Osteogenic sarcoma:
Methotrexate with citrovorum rescue after surgery
Dacarbazine (DTIC)
Ifofamide (Ifex)
Melanoma:
Tamoxifen (Nolvadex)
Salmon, S. E. and Sartorelli, A. C. Cancer Chemotherapy, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 903-904 (adapted from table 55-7)